For the first time, researchers have directly observed dopamine release in the human brain during moments of cognitive ...

For the first time, scientists have confirmed a neurobiochemical link between dopamine and cognitive flexibility, according ...

In a study by Gare et al. [7] a total of 66 patients with chronic renal failure and/or diabetes mellitus received low-dose dopamine (2 µg/kg/min) plus saline or saline alone for 48 hours.

Recently, timed-release bromocriptine (Cycloset), a sympatholytic dopamine D 2 receptor agonist, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes.

Dopamine’s effects in the brain are mediated by postsynaptic D1 and D2 receptors. Adenosine A1 and A2A receptors are uniquely positioned to counteract the excessive stimulation of dopamine receptors ...

By blocking dopamine-1 receptors, ecopipam is expected to reduce ... time to relapse for both pediatric and adult patients, 41.2% of participants taking ecopipam relapsed vs 67.9% of those taking ...

“That, to me, is surprising and new and exciting.” Analyzing activity of dopamine receptors also reinforced the role this neurotransmitter plays in changing stages of sexual behavior. Miyasaka ...